Next-generation regenerative gel (LDP-916/AGRG) for peripheral nerve injury (PNI) and spinal cord injury (SCI). Uses four FDA-recognized materials to guide axonal regrowth, bridge long nerve gaps, and provide a minimally invasive, scalable solution for nerve regeneration.